Values First Advisors, Inc. Talaris Therapeutics, Inc. Transaction History

Values First Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	SELL	$1.78 - $3.2 $37,178 - $66,838	-20,887 Reduced 39.49%	32,009 $97,000
Q1 2023 May 15, 2023	BUY	$1.09 - $2.09 $14,175 - $27,180	13,005 Added 32.6%	52,896 $99,000
Q4 2022 Jan 20, 2023	BUY	$0.94 - $1.64 $8,625 - $15,048	9,176 Added 29.87%	39,891 $0
Q3 2022 Dec 02, 2022	BUY	$2.3 - $5.03 $43,787 - $95,761	19,038 Added 163.04%	30,715 $81,000
Q2 2022 Jul 20, 2022	BUY	$4.51 - $9.85 $52,663 - $115,018	11,677 New	11,677 $53,000

75.7K

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of Values First Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Values First Advisors, Inc. with notifications on news.